1,092
Views
19
CrossRef citations to date
0
Altmetric
Research Paper

Evaluation of immunogen delivery by DNA immunization using non-invasive bioluminescence imaging

, , , , , & show all
Pages 2228-2236 | Received 06 Apr 2013, Accepted 27 Jun 2013, Published online: 03 Jul 2013

References

  • Lambert PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration?. Vaccine 2008; 26:3197 - 208; http://dx.doi.org/10.1016/j.vaccine.2008.03.095; PMID: 18486285
  • McCluskie MJ, Brazolot Millan CL, Gramzinski RA, Robinson HL, Santoro JC, Fuller JT, et al. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol Med 1999; 5:287 - 300; PMID: 10390545
  • Vandermeulen G, Staes E, Vanderhaeghen ML, Bureau MF, Scherman D, Préat V. Optimisation of intradermal DNA electrotransfer for immunisation. J Control Release 2007; 124:81 - 7; http://dx.doi.org/10.1016/j.jconrel.2007.08.010; PMID: 17854939
  • Lu QL, Bou-Gharios G, Partridge TA. Non-viral gene delivery in skeletal muscle: a protein factory. Gene Ther 2003; 10:131 - 42; http://dx.doi.org/10.1038/sj.gt.3301874; PMID: 12571642
  • Abdulhaqq SA, Weiner DB. DNA vaccines: developing new strategies to enhance immune responses. Immunol Res 2008; 42:219 - 32; http://dx.doi.org/10.1007/s12026-008-8076-3; PMID: 19066740
  • Lori F. DermaVir: a plasmid DNA-based nanomedicine therapeutic vaccine for the treatment of HIV/AIDS. Expert Rev Vaccines 2011; 10:1371 - 84; http://dx.doi.org/10.1586/erv.11.118; PMID: 21988301
  • Hinkula J. Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity. Expert Rev Vaccines 2007; 6:203 - 12; http://dx.doi.org/10.1586/14760584.6.2.203; PMID: 17408370
  • Babiuk LA, Pontarollo R, Babiuk S, Loehr B, van Drunen Littel-van den Hurk S. Induction of immune responses by DNA vaccines in large animals. Vaccine 2003; 21:649 - 58; http://dx.doi.org/10.1016/S0264-410X(02)00574-1; PMID: 12531334
  • Liu J, Kjeken R, Mathiesen I, Barouch DH. Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation. J Virol 2008; 82:5643 - 9; http://dx.doi.org/10.1128/JVI.02564-07; PMID: 18353952
  • Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 1999; 6:508 - 14; http://dx.doi.org/10.1038/sj.gt.3300847; PMID: 10476210
  • Grønevik E, Tollefsen S, Sikkeland LIB, Haug T, Tjelle TE, Mathiesen I. DNA transfection of mononuclear cells in muscle tissue. J Gene Med 2003; 5:909 - 17; http://dx.doi.org/10.1002/jgm.416; PMID: 14533200
  • Mezzanotte L, Que I, Kaijzel E, Branchini B, Roda A, Löwik C. Sensitive dual color in vivo bioluminescence imaging using a new red codon optimized firefly luciferase and a green click beetle luciferase. PLoS One 2011; 6:e19277; http://dx.doi.org/10.1371/journal.pone.0019277; PMID: 21544210
  • Bloquel C, Trollet C, Pradines E, Seguin J, Scherman D, Bureau MF. Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee. BMC Biotechnol 2006; 6:16; http://dx.doi.org/10.1186/1472-6750-6-16; PMID: 16524461
  • Starodubova E, Krotova O, Hallengärd D, Kuzmenko Y, Engström G, Legzdina D, et al. Cellular immunogenicity of novel gene immunogens in mice monitored by in vivo imaging. Mol Imaging 2012; 11:471 - 86; PMID: 23084248
  • Roos AK, Eriksson F, Timmons JA, Gerhardt J, Nyman U, Gudmundsdotter L, et al. Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment. PLoS One 2009; 4:e7226; http://dx.doi.org/10.1371/journal.pone.0007226; PMID: 19789652
  • Isaguliants M. In vivo monitoring of immune response in preclinical trials of genetic vaccines. In: DNA Vaccines 2012: The 21st Century Vaccine Technology: Expanding Research Horizons and Pathways to Product Licensure. San Diego, 2012.
  • Limberis MP, Bell CL, Wilson JM. Identification of the murine firefly luciferase-specific CD8 T-cell epitopes. Gene Ther 2009; 16:441 - 7; http://dx.doi.org/10.1038/gt.2008.177; PMID: 19129859
  • Stan R, Wolchok JD, Cohen AD. DNA vaccines against cancer. Hematol Oncol Clin North Am 2006; 20:613 - 36; http://dx.doi.org/10.1016/j.hoc.2006.02.004; PMID: 16762727
  • Buchan S, Grønevik E, Mathiesen I, King CA, Stevenson FK, Rice J. Electroporation as a “prime/boost” strategy for naked DNA vaccination against a tumor antigen. J Immunol 2005; 174:6292 - 8; PMID: 15879128
  • Bråve A, Hallengärd D, Gudmundsdotter L, Stout R, Walters R, Wahren B, et al. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen. Vaccine 2009; 27:3692 - 6; http://dx.doi.org/10.1016/j.vaccine.2009.04.013; PMID: 19428161
  • Murtaugh MP, Foss DL. Inflammatory cytokines and antigen presenting cell activation. Vet Immunol Immunopathol 2002; 87:109 - 21; http://dx.doi.org/10.1016/S0165-2427(02)00042-9; PMID: 12072225
  • Becker SM, Kuznetsov A. Thermal damage reduction associated with in vivo skin electroporation: A numerical investigation justifying aggressive pre-cooling. Int J Heat Mass Transfer 2007; 50:105 - 16; http://dx.doi.org/10.1016/j.ijheatmasstransfer.2006.06.030
  • Goldberg A, Rubinsky B. The effect of electroporation type pulsed electric fields on DNA in aqueous solution. Technol Cancer Res Treat 2010; 9:423 - 30; PMID: 20626208
  • Gothelf A, Eriksen J, Hojman P, Gehl J. Duration and level of transgene expression after gene electrotransfer to skin in mice. Gene Ther 2010; 17:839 - 45; http://dx.doi.org/10.1038/gt.2010.35; PMID: 20376097
  • Dupuis M, Denis-Mize K, Woo C, Goldbeck C, Selby MJ, Chen M, et al. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J Immunol 2000; 165:2850 - 8; PMID: 10946318
  • Johnson PA, Conway MA, Daly J, Nicolson C, Robertson J, Mills KH. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. J Gen Virol 2000; 81:1737 - 45; PMID: 10859379
  • Miller M, Rekas G, Dayball K, Wan YH, Bramson J. The efficacy of electroporated plasmid vaccines correlates with long-term antigen production in vivo. Vaccine 2004; 22:2517 - 23; http://dx.doi.org/10.1016/j.vaccine.2004.01.019; PMID: 15193376
  • Hallengärd D, Bråve A, Isaguliants M, Blomberg P, Enger J, Stout R, et al. A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines. Genet Vaccines Ther 2012; 10:5; http://dx.doi.org/10.1186/1479-0556-10-5; PMID: 22873174
  • Roos AK, Eriksson F, Walters DC, Pisa P, King AD. Optimization of skin electroporation in mice to increase tolerability of DNA vaccine delivery to patients. Mol Ther 2009; 17:1637 - 42; http://dx.doi.org/10.1038/mt.2009.120; PMID: 19532140
  • Hallengärd D, Haller BK, Maltais A-K, Gelius E, Nihlmark K, Wahren B, et al. Comparison of plasmid vaccine immunization schedules using intradermal in vivo electroporation. Clin Vaccine Immunol 2011; 18:1577 - 81; http://dx.doi.org/10.1128/CVI.05045-11; PMID: 21752954

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.